Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate 00527-0760-37
- Manufacturer
- Lannett Company, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- July 8, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215565
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 1.25 mg/1 |
| Amphetamine Sulfate | 1.25 mg/1 |
| Dextroamphetamine Saccharate | 1.25 mg/1 |
| Dextroamphetamine Sulfate | 1.25 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Selected Package
00527-0760-37Selected100 TABLET in 1 BOTTLE (0527-0760-37)